Mushrooms for Athletic Performance: The Cordyceps Trials

Cordyceps trials do not show a dependable rise in VO2 max or endurance performance. The studies seem to conflict because they differ in training status, product, length of use, and what they measured.

Cordyceps may shift some exercise thresholds in people who are not highly trained. Even so, human trials have not shown a dependable increase in VO2 max or endurance performance. If you already train seriously, the closest placebo-controlled trial in cyclists found no meaningful benefit. The answer looks mixed until you keep four facts together: who took part, which cordyceps product they took, how long they took it, and what the researchers measured. Marketing usually keeps the word "cordyceps" and drops the rest.

Why does training status change the answer?

Exercise studies do not start with identical people. Older adults who do not train for endurance may have more room to shift a lab threshold than cyclists whose aerobic systems have adapted to years of structured work. The choice of test changes the answer as well. Submaximal thresholds, VO2 max, time to exhaustion, and time-trial speed belong to one family of ideas, but each measures a different performance outcome.

So asking whether cordyceps "works" is misleading until you define the athlete and the outcome. Cordyceps can refer to different species and cultivated materials, so the name on a label is only the start. Your training only benefits if a finished product improves a result you can measure. Training status sets how much room a small change in the body has to show up, and how likely that change is to alter the work you complete.

The Older-Adult Cs-4 Pilot

The most favorable Cs-4 trial was a small double-blind pilot in 20 healthy adults aged 50 to 75. People in it took 333 mg three times daily for 12 weeks or took placebo. They then rode a graded cycle test while researchers analyzed each breath.

The Cs-4 group raised its metabolic threshold by 10.5% and its ventilatory threshold by 8.5%. These results suggest that the point where effort starts to lean on less sustainable metabolism moved higher during the test.

Retellings often shrink this result to "cordyceps improved aerobic performance," which claims more than the study supports. VO2 max did not improve, and the trial reported no race, time trial, or repeated-sprint outcome. Without one of those, you cannot tell whether people completed more real-world work.

Pilots like this one can flag a signal worth testing, but they do not give the final size or reliability of that signal. With only 20 participants, the study also cannot show which subgroups might respond or whether the change lasts after people stop the product. If you exercise for general health and do not compete, the threshold result may still be worth discussing. Read it as a narrow lab finding, and not as proof that cordyceps will make you faster.

Why is a threshold not the same as VO2 max?

Your ventilatory threshold marks the point during rising effort when breathing starts to climb out of step with the work. VO2 max is the highest rate at which your body can use oxygen during all-out effort, so it describes a different part of the performance curve. Thresholds can move while the maximum stays the same. You might hold a somewhat harder effort before breathing and metabolic strain speed up, yet still hit the same ceiling when the test turns maximal.

That shift could be useful, but it does not automatically produce a faster race. Technique, pacing, training load, fueling, motivation, heat, sleep, and how efficiently you move in your sport all sit between a lab threshold and your finishing time. Researchers can test that link directly with a time trial, a fixed-work test, or a sport-specific task. When those outcomes stay unchanged, the signal in the body may be real without being large enough to change results for the athlete.

The honest label for a submaximal lab change is a threshold change, and calling it a higher VO2 max misstates the result. Heart and blood-vessel health outside exercise is a separate question, with its own heart-health evidence.

The Trained-Cyclist Trial

The closest evidence for an endurance-trained reader is a five-week placebo-controlled trial in 22 trained male cyclists. They took 3 g per day of CordyMax Cs-4 or placebo while researchers logged their training. The team measured peak oxygen uptake, ventilatory threshold, and a work-based time trial.

None of the three outcomes improved. Peak oxygen uptake stayed similar, the threshold stayed at about the same share of peak uptake, and the time trial showed no supplement advantage.

The daily amount was higher than in the older-adult pilot, so you cannot write off the null result as simple underdosing. Instead, it suggests that training status, baseline fitness, or both may limit how much the product can add. The study enrolled only men and lasted five weeks, so it leaves open questions about sex, sport, and longer use.

Still, this trial fits a trained endurance athlete better than a positive pilot in older adults does. Its people and its performance task look more like your situation. It does not prove that no athlete could ever respond. For this group, the strongest trial gives you a low expectation of a meaningful average benefit.

Blend Studies in Young Active Adults

One frequently cited study tested a multi-mushroom blend in 28 young, recreationally active adults. After one week, the active and placebo groups did not differ clearly in VO2 max, time to exhaustion, or ventilatory threshold. Ten volunteers then kept taking the active product for two more weeks. The authors reported exploratory gains after three weeks, but that continuation was small, lost the full randomized comparison, and used a blend that held more than cordyceps.

This study leaves room for a role of longer use. Its positive part is still too small and too product-specific to support a broad cordyceps claim. Another blend, tested in a 14-week multi-ingredient training trial, runs into the same attribution problem. The supplement improved some weekly training measures, but by the end of the program it gave no advantage over placebo in body composition, overall training and performance outcomes, or blood markers of health.

When a blend contains several active ingredients, even a real effect would not tell you which ingredient caused it. So a product page cannot cite the blend and then sell cordyceps as though researchers had tested it alone.

Hormone and Antioxidant Markers

One study gave seven amateur cyclists a combination of Ophiocordyceps sinensis and reishi for three months. The uncontrolled cyclist study reported changes in the testosterone-to-cortisol ratio and in antioxidant capacity. It had no placebo group and did not measure speed, power, VO2 max, time to exhaustion, or a time trial.

Markers like these give researchers a hypothesis to test. They sit upstream of the outcome you care about, so a saliva ratio cannot tell you whether your next interval session, long ride, or race will improve.

The reishi part makes attribution even harder, because reishi research concerns different outcomes and preparations. We can keep the reported marker result and still decline the performance claim built on top of it. Useful performance studies need a performance endpoint, and without one the finding stays mechanistic or exploratory.

Matching a Shelf Product to the Trial Material

The trials did not use one interchangeable substance. They used named Cs-4 products, a cultivated C. militaris blend, or multi-ingredient formulas that also held reishi and other mushroom material. The word "cordyceps" on a front label may refer to C. militaris fruiting body, cultured O. sinensis mycelium, an extract, a powder, or a proprietary blend.

Evidence does not transfer automatically between those forms, since extraction ratios and solvents vary from one product to the next. Before you apply a study to a product, compare these fields one by one.

For identity and contamination, a lab certificate can reduce uncertainty, but it does not prove that the product improves performance. Do not copy a study amount onto a different preparation. You can compare label units against the trial amounts, yet strain, extraction, and blend makeup still govern whether the number means anything as evidence.

How should an athlete decide on cordyceps?

If you are a trained endurance athlete, the closest controlled trial gives little reason to expect a meaningful performance gain. If you are older, less trained, and interested in exercise capacity, the threshold pilot fits you better. Even so, it did not show a higher VO2 max or a real-world performance gain.

Competitive athletes carry an extra risk, because a contaminated supplement can cause a rule violation even when the label leaves out the prohibited substance. USADA's supplement guidance explains why no certification can bring that risk to zero.

Before a clinician-approved trial, review your health conditions and medicines for possible interactions with cordyceps, and go through the side effects worth watching for. Memorial Sloan Kettering's cordyceps monograph also lists situations that call for an interaction review.

If you go ahead, change one thing at a time. Record the exact product, training block, sleep, illness, and the performance test you chose. Your own result may help you judge whether the cost is worth it. It cannot turn a small trial or a self-test into a general claim.

For most trained athletes, the best-supported choice is to put training, recovery, fueling, and sport-specific testing ahead of a mushroom supplement. Those levers have larger and more predictable effects, while the closest cordyceps evidence in trained people is null.